ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Human Fetal Cell Therapy in Huntington's Disease: A Randomized, Multicenter, Phase II Trial
Movement Disorders
◽
10.1002/mds.28201
◽
2020
◽
Vol 35
(8)
◽
pp. 1323-1335
◽
Cited By ~ 1
Author(s):
Anne‐Catherine Bachoud‐Lévi
◽
Catherine Schramm
◽
Philippe Remy
◽
Ghislaine Aubin
◽
Serge Blond
◽
...
Keyword(s):
Cell Therapy
◽
Huntington's Disease
◽
Huntington’S Disease
◽
Phase Ii
◽
Phase Ii Trial
◽
Fetal Cell
◽
Multicenter Phase
Download Full-text
Related Documents
Cited By
References
Q23 A double blind, cross over, placebo-controlled, phase II trial of Sativex in Huntington's Disease
Journal of Neurology Neurosurgery & Psychiatry
◽
10.1136/jnnp-2012-303524.193
◽
2012
◽
Vol 83
(Suppl 1)
◽
pp. A62.2-A62
◽
Cited By ~ 1
Author(s):
JG Caldentey
◽
JL Lopéz-Sendón
◽
P Trigo
◽
C Ruiz
◽
GG Ribas
◽
...
Keyword(s):
Huntington's Disease
◽
Huntington’S Disease
◽
Phase Ii
◽
Phase Ii Trial
◽
Double Blind
Download Full-text
N02 Safety And Tolerability Of Selisistat For The Treatment Of Huntington's Disease: Results From A Randomised, Double-blind, Placebo-controlled Phase Ii Trial
Journal of Neurology Neurosurgery & Psychiatry
◽
10.1136/jnnp-2014-309032.294
◽
2014
◽
Vol 85
(Suppl 1)
◽
pp. A102-A102
◽
Cited By ~ 4
Author(s):
R. Reilmann
◽
F. Squitieri
◽
J. Priller
◽
C. Saft
◽
C. Mariotti
◽
...
Keyword(s):
Huntington's Disease
◽
Huntington’S Disease
◽
Phase Ii
◽
Phase Ii Trial
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
An open-label, multicenter phase II trial of SUNITINIB for patients with chemorefractory metastatic gastric cancer
Zeitschrift für Gastroenterologie
◽
10.1055/s-0030-1263569
◽
2010
◽
Vol 48
(08)
◽
Cited By ~ 1
Author(s):
M Moehler
◽
J Hartmann
◽
F Lordick
◽
S Al-Batran
◽
P Reimer
◽
...
Keyword(s):
Gastric Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Metastatic Gastric Cancer
◽
Open Label
◽
Multicenter Phase
Download Full-text
Temsirolimus in women with platinum-resistant ovarian cancer or advanced/recurrent endometrial cancer: a multicenter phase II trial of the AGO Study Group (AGO-GYN 8)
Geburtshilfe und Frauenheilkunde
◽
10.1055/s-0034-1388557
◽
2014
◽
Vol 74
(S 01)
◽
Author(s):
F Hilpert
◽
C Kurzeder
◽
B Schmalfeldt
◽
P Neuser
◽
N de Gregorio
◽
...
Keyword(s):
Ovarian Cancer
◽
Endometrial Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Study Group
◽
Multicenter Phase
◽
Platinum Resistant
◽
Recurrent Endometrial Cancer
Download Full-text
Faculty Opinions recommendation of Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1157701.617915
◽
2009
◽
Author(s):
John Newell-Price
◽
Miguel Debono
Keyword(s):
Phase Ii
◽
Cushing’S Disease
◽
Phase Ii Trial
◽
Somatostatin Analog
◽
Cushing's Disease
◽
Multicenter Phase
Download Full-text
Faculty Opinions recommendation of A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718113892.793485442
◽
2013
◽
Author(s):
Luca Persani
Keyword(s):
Thyroid Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Locally Advanced
◽
Multicenter Phase
◽
Histologic Subtypes
◽
Metastatic Thyroid Cancer
Download Full-text
Faculty Opinions recommendation of Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718128610.793486222
◽
2013
◽
Author(s):
David Kushner
◽
Erin Medlin
Keyword(s):
Ovarian Cancer
◽
Epithelial Ovarian Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Resistant Refractory
◽
Multicenter Phase
◽
Platinum Resistant
◽
Etirinotecan Pegol
Download Full-text
A multicenter, Phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma
Cancer
◽
10.1002/(sici)1097-0142(19990215)85:4<786::aid-cncr5>3.0.co;2-9
◽
1999
◽
Vol 85
(4)
◽
pp. 786-795
◽
Cited By ~ 141
Author(s):
Mace L. Rothenberg
◽
John V. Cox
◽
Russell F. DeVore
◽
John D. Hainsworth
◽
Richard Pazdur
◽
...
Keyword(s):
Colorectal Carcinoma
◽
Phase Ii
◽
Phase Ii Trial
◽
Multicenter Phase
◽
Previously Treated
Download Full-text
UPDATED RESULTS OF THE FIL “MIRO” STUDY, A MULTICENTER PHASE II TRIAL COMBINING LOCAL RADIOTHERAPY AND MRD‐DRIVEN IMMUNOTHERAPY IN EARLY‐STAGE FOLLICULAR LYMPHOMA
Hematological Oncology
◽
10.1002/hon.31_2880
◽
2021
◽
Vol 39
(S2)
◽
Author(s):
A. Pulsoni
◽
M. E. Tosti
◽
S. Ferrero
◽
S. Luminari
◽
A. Dondi
◽
...
Keyword(s):
Follicular Lymphoma
◽
Phase Ii
◽
Phase Ii Trial
◽
Early Stage
◽
Multicenter Phase
Download Full-text
265O Anlotinib in locally advanced or metastatic radioiodine-refractory differentiated thyroid carcinoma: A randomized, double-blind, multicenter phase II trial
Annals of Oncology
◽
10.1016/j.annonc.2020.10.259
◽
2020
◽
Vol 31
◽
pp. S1347
Author(s):
Y. Chi
◽
M. Gao
◽
Y. Zhang
◽
F. Shi
◽
Y. Cheng
◽
...
Keyword(s):
Thyroid Carcinoma
◽
Phase Ii
◽
Phase Ii Trial
◽
Locally Advanced
◽
Differentiated Thyroid Carcinoma
◽
Double Blind
◽
Multicenter Phase
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close